Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice (original) (raw)

References

1. Seder, R. A., Chang, L. J., Enama, M. E., Zephir, K. L., Sarwar, U. N. & Gordon, I. J. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359–1365 (2013).
   Article CAS PubMed Google Scholar
2. Ishizuka, A. S., Lyke, K. E., DeZure, A., Berry, A. A., Richie, T. L. & Mendoza, F. H. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614–623 (2016).
   Article CAS PubMed Google Scholar
3. Kester, K. E., Cummings, J. F., Ofori-Anyinam, O., Ockenhouse, C. F., Krzych, U. & Moris, P. et al. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200, 337–346 (2009).
   Article CAS PubMed Google Scholar
4. Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O. & Leach, A. et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N. Eng. J. Med. 368, 1111–1120 (2013).
   Article CAS Google Scholar
5. White, M. T., Bejon, P., Olotu, A., Griffin, J. T., Riley, E. M. & Kester, K. E. et al. The relationship between RTS,S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection. PLoS One 8, e61395 (2013).
   Article CAS PubMed PubMed Central Google Scholar
6. Behet, M. C., Foquet, L., van Gemert, G. J., Bijker, E. M., Meuleman, P. & Leroux-Roels, G. et al. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 13, 136 (2014).
   Article PubMed PubMed Central Google Scholar
7. Epstein, J. E., Paolino, K. M., Richie, T. L., Sedegah, M., Singer, A. & Ruben, A. J. et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight 2, e89154 (2017).
   Article PubMed PubMed Central Google Scholar
8. Lyke, K. E., Ishizuka, A. S., Berry, A. A., Chakravarty, S., DeZure, A. & Enama, M. E. et al. Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc. Natl. Acad. Sci. USA 114, 2711–2716 (2017).
   Article CAS PubMed PubMed Central Google Scholar
9. Vanderberg, J. P. & Frevert, U. Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int. J. Parasitol. 34, 991–996 (2004).
   Article PubMed Google Scholar
10. Kebaier, C., Voza, T. & Vanderberg, J. Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice. PLoS Pathog. 5, e1000399 (2009).
    Article PubMed PubMed Central Google Scholar
11. Sinnis, P. & Zavala, F. The skin stage of malaria infection: biology and relevance to the malaria vaccine effort. Future Microbiol. 3, 275–278 (2008).
    Article PubMed Google Scholar
12. Sinnis, P. & Zavala, F. The skin: where malaria infection and the host immune response begin. Semin. Immunopathol. 34, 787–792 (2012).
    Article CAS PubMed PubMed Central Google Scholar
13. Cha, S. J., Kim, M. S., Pandey, A. & Jacobs-Lorena, M. Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion. J. Exp. Med. 213, 2099–2112 (2016).
    Article CAS PubMed PubMed Central Google Scholar
14. Lindner, S. E., Swearingen, K. E., Harupa, A., Vaughan, A. M., Sinnis, P. & Moritz, R. L. et al. Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Mol. Cell. Proteomics 12, 1127–1143 (2013).
    Article CAS PubMed PubMed Central Google Scholar
15. Swearingen, K. E., Lindner, S. E., Shi, L., Shears, M. J., Harupa, A. & Hopp, C. S. et al. Interrogating the Plasmodium sporozoite surface: identification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics. PLoS Pathog. 12, e1005606 (2016).
    Article PubMed PubMed Central Google Scholar
16. Espinosa, D. A., Yadava, A., Angov, E., Maurizio, P. L., Ockenhouse, C. F. & Zavala, F. Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy. Infect. Immun. 81, 2882–2887 (2013).
    Article CAS PubMed PubMed Central Google Scholar
17. Bauza, K., Malinauskas, T., Pfander, C., Anar, B., Jones, E. Y. & Billker, O. et al. Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites. Infect. Immun. 82, 1277–1286 (2014).
    Article PubMed PubMed Central Google Scholar
18. Persson, C., Oliveira, G. A., Sultan, A. A., Bhanot, P., Nussenzweig, V. & Nardin, E. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. J. Immunol. 169, 6681–6685 (2002).
    Article CAS PubMed Google Scholar
19. Sauerwein, R. W., Roestenberg, M. & Moorthy, V. S. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat. Rev. Immunol. 11, 57–64 (2011).
    Article CAS PubMed Google Scholar
20. Cummings, J. F., Spring, M. D., Schwenk, R. J., Ockenhouse, C. F., Kester, K. E. & Polhemus, M. E. et al. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28, 5135–5144 (2010).
    Article CAS PubMed Google Scholar
21. Kester, K. E., Gray Heppner, D. Jr., Moris, P., Ofori-Anyinam, O., Krzych, U. & Tornieporth, N. et al. Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naive adults. Vaccine 32, 6683–6691 (2014).
    Article CAS PubMed Google Scholar
22. McConkey, S. J., Reece, W. H., Moorthy, V. S., Webster, D., Dunachie, S. & Butcher, G. et al. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9, 729–735 (2003).
    Article CAS PubMed Google Scholar
23. Ockenhouse, C. F., Sun, P. F., Lanar, D. E., Wellde, B. T., Hall, B. T. & Kester, K. et al. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J. Infect. Dis. 177, 1664–1673 (1998).
    Article CAS PubMed Google Scholar
24. Porter, D. W., Thompson, F. M., Berthoud, T. K., Hutchings, C. L., Andrews, L. & Biswas, S. et al. A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine 29, 7514–7522 (2011).
    Article CAS PubMed PubMed Central Google Scholar
25. Richie, T. L., Charoenvit, Y., Wang, R., Epstein, J. E., Hedstrom, R. C. & Kumar, S. et al. Clinical trial in healthy malaria-naive adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. Hum. Vaccin. Immunother. 8, 1564–1584 (2012).
    Article CAS PubMed PubMed Central Google Scholar
26. Steel, R. W., Kappe, S. H. & Sack, B. K. An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials. Future Microbiol. 11, 1563–1579 (2016).
    Article CAS PubMed Google Scholar
27. Amino, R., Giovannini, D., Thiberge, S., Gueirard, P., Boisson, B. & Dubremetz, J. F. et al. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe 3, 88–96 (2008).
    Article CAS PubMed Google Scholar
28. Tavares, J., Formaglio, P., Thiberge, S., Mordelet, E., Van Rooijen, N. & Medvinsky, A. et al. Role of host cell traversal by the malaria sporozoite during liver infection. J. Exp. Med. 210, 905–915 (2013).
    Article CAS PubMed PubMed Central Google Scholar
29. Vaughan, A. M., Mikolajczak, S. A., Wilson, E. M., Grompe, M., Kaushansky, A. & Camargo, N. et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J. Clin. Invest. 122, 3618–3628 (2012).
    Article CAS PubMed PubMed Central Google Scholar
30. Mikolajczak, S. A., Vaughan, A. M., Kangwanrangsan, N., Roobsoong, W., Fishbaugher, M. & Yimamnuaychok, N. et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 17, 526–535 (2015).
    Article CAS PubMed PubMed Central Google Scholar
31. Foquet, L., Hermsen, C. C., van Gemert, G. J., Van Braeckel, E., Weening, K. E. & Sauerwein, R. et al. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J. Clin. Invest. 124, 140–144 (2014).
    Article CAS PubMed Google Scholar
32. Foquet, L., Meuleman, P., Hermsen, C. C., Sauerwein, R. & Leroux-Roels, G. Assessment of parasite liver-stage burden in human-liver chimeric mice. Methods Mol. Biol. 1325, 59–68 (2015).
    Article CAS PubMed Google Scholar
33. Sack, B. K., Miller, J. L., Vaughan, A. M., Douglass, A., Kaushansky, A. & Mikolajczak, S. et al. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect. Immun. 82, 808–817 (2014).
    Article PubMed PubMed Central Google Scholar
34. Kublin, J. G., Mikolajczak, S. A., Sack, B. K., Fishbaugher, M. E., Seilie, A. & Shelton, L., et al. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects. Sci. Transl. Med. 9, 371 (2017).
35. Keitany, G. J., Sack, B., Smithers, H., Chen, L., Jang, I. K. & Sebastian, L. et al. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria. Infect. Immun. 82, 5143–5153 (2014).
    Article PubMed PubMed Central Google Scholar
36. Vaughan, A. M., Mikolajczak, S. A., Camargo, N., Lakshmanan, V., Kennedy, M. & Lindner, S. E. et al. A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Mol. Biochem. Parasitol. 186, 143–147 (2012).
    Article CAS PubMed Google Scholar
37. Kipps, T. J., Parham, P., Punt, J. & Herzenberg, L. A. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 161, 1–17 (1985).
    Article CAS PubMed Google Scholar
38. Overdijk, M. B., Verploegen, S., Ortiz Buijsse, A., Vink, T., Leusen, J. H. & Bleeker, W. K. et al. Crosstalk between human IgG isotypes and murine effector cells. J. Immunol. 189, 3430–3438 (2012).
    Article CAS PubMed Google Scholar
39. Gonzalez-Quintela, A., Alende, R., Gude, F., Campos, J., Rey, J. & Meijide, L. M. et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin. Exp. Immunol. 151, 42–50 (2008).
    Article CAS PubMed PubMed Central Google Scholar
40. Roestenberg, M., McCall, M., Hopman, J., Wiersma, J., Luty, A. J. & van Gemert, G. J. et al. Protection against a malaria challenge by sporozoite inoculation. N. Eng. J. Med. 361, 468–477 (2009).
    Article CAS Google Scholar
41. Roestenberg, M., Teirlinck, A. C., McCall, M. B., Teelen, K., Makamdop, K. N. & Wiersma, J. et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770–1776 (2011).
    Article CAS PubMed Google Scholar
42. Hodgson, S. H., Douglas, A. D., Edwards, N. J., Kimani, D., Elias, S. C. & Chang, M. et al. Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies. Malar. J. 14, 33 (2015).
    Article PubMed PubMed Central Google Scholar
43. Murphy, S. C., Prentice, J. L., Williamson, K., Wallis, C. K., Fang, F. C. & Fried, M. et al. Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. Am. J. Trop. Med. Hyg. 86, 383–394 (2012).
    Article CAS PubMed PubMed Central Google Scholar
44. Potocnjak, P., Yoshida, N., Nussenzweig, R. S. & Nussenzweig, V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 151, 1504–1513 (1980).
    Article CAS PubMed Google Scholar
45. Charoenvit, Y., Sedegah, M., Yuan, L. F., Gross, M., Cole, C. & Bechara, R. et al. Active and passive immunization against Plasmodium yoelii sporozoites. Bull. World Health Organ. 68, Suppl:26–Suppl:32 (1990).
    Google Scholar
46. Charoenvit, Y., Mellouk, S., Cole, C., Bechara, R., Leef, M. F. & Sedegah, M. et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 146, 1020–1025 (1991).
    CAS PubMed Google Scholar
47. Vanderberg, J., Mueller, A. K., Heiss, K., Goetz, K., Matuschewski, K. & Deckert, M. et al. Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. Am. J. Pathol. 171, 1405–1406 (2007). author reply 6.
    Article PubMed Google Scholar
48. Bijker, E. M., Bastiaens, G. J., Teirlinck, A. C., van Gemert, G. J., Graumans, W. & van de Vegte-Bolmer, M. et al. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci USA 110, 7862–7867 (2013).
    Article CAS PubMed PubMed Central Google Scholar
49. Bijker, E. M., Teirlinck, A. C., Schats, R., van Gemert, G. J., van de Vegte-Bolmer, M. & van Lieshout, L. et al. Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J. Infect. Dis. 210, 1605–1615 (2014).
    Article PubMed PubMed Central Google Scholar
50. Epstein, J. E., Tewari, K., Lyke, K. E., Sim, B. K., Billingsley, P. F. & Laurens, M. B. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity. Science 334, 475–480 (2011).
    Article CAS PubMed Google Scholar
51. Doll, K. L. & Harty, J. T. Correlates of protective immunity following whole sporozoite vaccination against malaria. Immunol. Res. 59, 166–176 (2014).
    Article CAS PubMed PubMed Central Google Scholar
52. Sheehy, S. H., Duncan, C. J., Elias, S. C., Choudhary, P., Biswas, S. & Halstead, F. D. et al. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol. Ther. 20, 2355–2368 (2012).
    Article CAS PubMed PubMed Central Google Scholar
53. Hill, A. V., Reyes-Sandoval, A., O’Hara, G., Ewer, K., Lawrie, A. & Goodman, A. et al. Prime-boost vectored malaria vaccines: progress and prospects. Hum. Vaccin. 6, 78–83 (2010).
    Article CAS PubMed Google Scholar
54. Hodgson, S. H., Ewer, K. J., Bliss, C. M., Edwards, N. J., Rampling, T. & Anagnostou, N. A. et al. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals. J. Infect. Dis. 211, 1076–1086 (2015).
    Article CAS PubMed Google Scholar
55. Bruna-Romero, O., Hafalla, J. C., Gonzalez-Aseguinolaza, G., Sano, G., Tsuji, M. & Zavala, F. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int. J. Parasitol. 31, 1499–1502 (2001).
    Article CAS PubMed Google Scholar
56. Ak, M., Bower, J. H., Hoffman, S. L., Sedegah, M., Lees, A. & Carter, M. et al. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites. Infect. Immun. 61, 2493–2497 (1993).
    CAS PubMed PubMed Central Google Scholar
57. Yilmaz, B., Portugal, S., Tran, T. M., Gozzelino, R., Ramos, S. & Gomes, J. et al. Gut microbiota elicits a protective immune response against malaria transmission. Cell. 159, 1277–1289 (2014).
    Article CAS PubMed PubMed Central Google Scholar
58. Felgner, P. L., Roestenberg, M., Liang, L., Hung, C., Jain, A. & Pablo, J. et al. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci. Rep. 3, 3549 (2013).
    Article PubMed PubMed Central Google Scholar
59. Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85, 573–576 (1988).
    Article CAS PubMed PubMed Central Google Scholar
60. Rodrigues, M., Nussenzweig, R. S. & Zavala, F. The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 80, 1–5 (1993).
    CAS PubMed PubMed Central Google Scholar
61. Celada, A., Cruchaud, A. & Perrin, L. H. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin. Exp. Immunol. 47, 635–644 (1982).
    CAS PubMed PubMed Central Google Scholar
62. Mazurier, F., Fontanellas, A., Salesse, S., Taine, L., Landriau, S. & Moreau-Gaudry, F. et al. A novel immunodeficient mouse model—RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon Cytokine Res. 19, 533–541 (1999).
    Article CAS PubMed Google Scholar
63. Miller, J. L., Murray, S., Vaughan, A. M., Harupa, A., Sack, B. & Baldwin, M. et al. Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii. PLoS One 8, e60820 (2013).
    Article CAS PubMed PubMed Central Google Scholar
64. Foquet, L., Hermsen, C. C., van Gemert, G. J., Van Braeckel, E., Weening, K. E. & Sauerwein, R., et al. Vaccine-induced monoclonal antibodies targetingcircumsporozoite protein prevent Plasmodium falciparum infection. J. Clin. Invest. 124, 140–144 (2013)
65. Murphy, S. C., Daza, G., Chang, M. & Coombs, R. Laser cutting eliminates nucleic acid cross-contamination in dried-blood-spot processing. J. Clin. Microbiol. 50, 4128–4130 (2012).
    Article PubMed PubMed Central Google Scholar
66. Billman, Z. P., Seilie, A. M. & Murphy, S. C. Purification of Plasmodium sporozoites enhances parasite-specific CD8+ T cell responses. Infect. Immun. 84, 2233–2242 (2016).
    Article CAS PubMed PubMed Central Google Scholar
67. Kaushansky, A., Rezakhani, N., Mann, H. & Kappe, S. H. Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites. Mol. Biochem. Parasitol. 183, 100–103 (2012).
    Article CAS PubMed PubMed Central Google Scholar
68. Douglass, A. N., Metzger, P. G., Kappe, S. H. & Kaushansky, A. Flow cytometry-based assessment of antibody function against malaria pre-erythrocytic infection. Methods Mol. Biol. 1325, 49–58 (2015).
    Article CAS PubMed Google Scholar

Download references